Advanced in Heart Failure with Preserved Ejection Fraction (HFpEF)

Petr Neuzil

Prague, PR, CZ 
Advanced in Heart Failure with Preserved Ejection Fraction (HFpEF)
Prague, PR, CZ 
OverviewLocationsClinical Research

Overview

Petr Neuzil practices in Prague, Czech Republic. Mr. Neuzil is rated as an Advanced expert by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). His top areas of expertise are Atrial Fibrillation, Arrhythmias, Ventricular Tachycardia, Cardiac Ablation, and Pacemaker Implantation.

His clinical research consists of co-authoring 282 peer reviewed articles and participating in 35 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 5 articles and participated in 2 clinical trials in the study of Heart Failure with Preserved Ejection Fraction (HFpEF).

Gender
Male

Locations

Prague, PR, Czech Republic
Other Locations
Brno, JM, Czech Republic

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

34 Clinical Trials

Assessment of the WATCHMAN™ Device in Patients Unsuitable for Oral Anticoagulation (ASAP-TOO)
Assessment of the WATCHMAN™ Device in Patients Unsuitable for Oral Anticoagulation (ASAP-TOO)
Enrollment Status: Completed
Publish Date: September 26, 2025
Intervention Type: Device, Drug
Study Phase: Not Applicable
Aveir Dual-Chamber Leadless i2i IDE Study
Aveir Dual-Chamber Leadless i2i IDE Study
Enrollment Status: Active_not_recruiting
Publish Date: August 15, 2025
Intervention Type: Device
Study Phase: Not Applicable
Secondary Prevention of Cardiovascular Disease in the Elderly Trial
Secondary Prevention of Cardiovascular Disease in the Elderly Trial
Enrollment Status: Completed
Publish Date: May 23, 2025
Intervention Type: Drug
Study Drugs: Cardiovascular Polypill, Treatment Prevention for Secondary CV
Study Phase: Phase 3
Ultrasound-Based Renal Sympathetic Denervation as Adjunctive Upstream Therapy During Atrial Fibrillation Ablation: A Pilot Study
Ultrasound-Based Renal Sympathetic Denervation as Adjunctive Upstream Therapy During Atrial Fibrillation Ablation: A Pilot Study
Enrollment Status: Completed
Publish Date: May 08, 2025
Intervention Type: Device
Study Phase: Not Applicable
A Prospective Clinical Evaluation of the DiamondTemp™ System for the Treatment of Persistent Atrial Fibrillation
A Prospective Clinical Evaluation of the DiamondTemp™ System for the Treatment of Persistent Atrial Fibrillation
Enrollment Status: Completed
Publish Date: April 24, 2025
Intervention Type: Device
Study Phase: Not Applicable
Advanced Cardiac Therapeutics DiamondTemp TempeRAture-Controlled and Contact Sensing RF Ablation Clinical Trial for Atrial Fibrillation
Advanced Cardiac Therapeutics DiamondTemp TempeRAture-Controlled and Contact Sensing RF Ablation Clinical Trial for Atrial Fibrillation
Enrollment Status: Completed
Publish Date: February 13, 2025
Intervention Type: Device
Study Phase: Not Applicable
Safety and Performance Evaluation of the AccuCinch® Ventricular Restoration System for the Treatment of Heart Failure With or Without Functional Mitral Regurgitation Due to Dilated Ischemic or Non-Ischemic Cardiomyopathy - The CorCinch-EU Study
Safety and Performance Evaluation of the AccuCinch® Ventricular Restoration System for the Treatment of Heart Failure With or Without Functional Mitral Regurgitation Due to Dilated Ischemic or Non-Ischemic Cardiomyopathy - The CorCinch-EU Study
Enrollment Status: Active_not_recruiting
Publish Date: January 29, 2025
Intervention Type: Device
Study Phase: Not Applicable
PersAFOne III: Feasibility Study of the FARAPULSE Pulsed Field Ablation System Plus - PersAF in the Treatment of Persistent Atrial Fibrillation
PersAFOne III: Feasibility Study of the FARAPULSE Pulsed Field Ablation System Plus - PersAF in the Treatment of Persistent Atrial Fibrillation
Enrollment Status: Completed
Publish Date: January 08, 2025
Intervention Type: Device
Study Phase: Not Applicable
The FARAPULSE FARA-Freedom Trial A Prospective Open Label Single Arm Post Market Clinical Follow-Up Trial of the FARAPULSE Pulsed Field Ablation System in Patients With Paroxysmal Atrial Fibrillation
The FARAPULSE FARA-Freedom Trial A Prospective Open Label Single Arm Post Market Clinical Follow-Up Trial of the FARAPULSE Pulsed Field Ablation System in Patients With Paroxysmal Atrial Fibrillation
Enrollment Status: Completed
Publish Date: October 17, 2024
Intervention Type: Device
Study Phase: Not Applicable
The REDUCE FMR Trial: Safety and Efficacy of the Carillon Mitral Contour System® in Reducing Functional Mitral Regurgitation (FMR) Associated With Heart Failure
The REDUCE FMR Trial: Safety and Efficacy of the Carillon Mitral Contour System® in Reducing Functional Mitral Regurgitation (FMR) Associated With Heart Failure
Enrollment Status: Completed
Publish Date: August 05, 2024
Intervention Type: Device
Study Phase: Not Applicable
Cardiac Contractility Modulation Therapy in Subjects With Heart Failure With Preserved Ejection Fraction
Cardiac Contractility Modulation Therapy in Subjects With Heart Failure With Preserved Ejection Fraction
Enrollment Status: Completed
Publish Date: April 23, 2024
Intervention Type: Device
Study Phase: Not Applicable
PersAFOne II(Pronounced Per-'Se-fa-nē 2); Feasibility Study of the FARAPULSE™ Cardiac Ablation System Plus in the Treatment of Persistent Atrial Fibrillation
PersAFOne II(Pronounced Per-'Se-fa-nē 2); Feasibility Study of the FARAPULSE™ Cardiac Ablation System Plus in the Treatment of Persistent Atrial Fibrillation
Enrollment Status: Completed
Publish Date: February 28, 2024
Intervention Type: Device
Study Phase: Not Applicable
Endovascular Ablation of the Greater Splanchnic Nerve in Subjects Having Heart Failure With Preserved Ejection Fraction - First In-human Feasibility Study
Endovascular Ablation of the Greater Splanchnic Nerve in Subjects Having Heart Failure With Preserved Ejection Fraction - First In-human Feasibility Study
Enrollment Status: Enrolling_by_invitation
Publish Date: February 02, 2024
Intervention Type: Device
Study Phase: Not Applicable
PersAFOne: Feasibility Study of the FARAPULSE™ Endocardial Ablation System in the Treatment of Persistent Atrial Fibrillation
PersAFOne: Feasibility Study of the FARAPULSE™ Endocardial Ablation System in the Treatment of Persistent Atrial Fibrillation
Enrollment Status: Completed
Publish Date: January 30, 2024
Intervention Type: Device
Study Phase: Not Applicable
Cryoablation for Monomorphic Ventricular Tachycardia
Cryoablation for Monomorphic Ventricular Tachycardia
Enrollment Status: Active_not_recruiting
Publish Date: January 30, 2024
Intervention Type: Device
Study Phase: Not Applicable
The Pulsed Field Ablation System Study for Atrial Fibrillation (PFA-AF)
The Pulsed Field Ablation System Study for Atrial Fibrillation (PFA-AF)
Enrollment Status: Completed
Publish Date: November 13, 2023
Intervention Type: Device
Study Phase: Not Applicable
Clinical Study of the BioVentrix Revivent TC™ System for Treatment of Left Ventricular Aneurysms (ALIVE)
Clinical Study of the BioVentrix Revivent TC™ System for Treatment of Left Ventricular Aneurysms (ALIVE)
Enrollment Status: Active_not_recruiting
Publish Date: August 22, 2023
Intervention Type: Device
Study Phase: Not Applicable
Randomized Trial to Study the Efficacy and Adverse Effects of the Subcutaneous and Transvenous Implantable Cardioverter Defibrillator (ICD) in Patients With a Class I or IIa Indication for ICD Without an Indication for Pacing
Randomized Trial to Study the Efficacy and Adverse Effects of the Subcutaneous and Transvenous Implantable Cardioverter Defibrillator (ICD) in Patients With a Class I or IIa Indication for ICD Without an Indication for Pacing
Enrollment Status: Unknown
Publish Date: May 09, 2023
Intervention Type: Device
Study Phase: Not Applicable
Clinical Evaluation of Safety and Effectiveness of the BackBeat Medical Moderato System in Patients With Hypertension: A Double-Blind Randomized Trial
Clinical Evaluation of Safety and Effectiveness of the BackBeat Medical Moderato System in Patients With Hypertension: A Double-Blind Randomized Trial
Enrollment Status: Unknown
Publish Date: December 14, 2022
Intervention Type: Device
Study Phase: Not Applicable
Addendum to Protocol CS-03: Clinical Evaluation of Safety and Effectiveness of the BackBeat Medical Moderato System in Patients With Hypertension: A Double-Blind Randomized Trial, NCT02837445
Addendum to Protocol CS-03: Clinical Evaluation of Safety and Effectiveness of the BackBeat Medical Moderato System in Patients With Hypertension: A Double-Blind Randomized Trial, NCT02837445
Enrollment Status: Unknown
Publish Date: November 03, 2022
Intervention Type: Device
Study Phase: Phase 1/Phase 2
Bipolar Catheter Ablation for the Treatment of Refractory Scar-Related Ventricular Arrhythmia
Bipolar Catheter Ablation for the Treatment of Refractory Scar-Related Ventricular Arrhythmia
Enrollment Status: Completed
Publish Date: November 01, 2022
Intervention Type: Device
Study Phase: Not Applicable
A Prospective, Multi-center, Post Market Randomized Controlled Trial Comparing VT Ablation Outcomes Using Remote MAGNETIC Navigation Guided Substrate Mapping and Ablation Versus Manual Approach in a Low LVEF Population
A Prospective, Multi-center, Post Market Randomized Controlled Trial Comparing VT Ablation Outcomes Using Remote MAGNETIC Navigation Guided Substrate Mapping and Ablation Versus Manual Approach in a Low LVEF Population
Enrollment Status: Terminated
Publish Date: September 27, 2022
Intervention Type: Device
Study Phase: Not Applicable
Utilizing Novel Dipole Density Capabilities to Objectively Visualize the Etiology of Recurrent Atrial Fibrillation Following a Failed AF Ablation (RECOVER AF)
Utilizing Novel Dipole Density Capabilities to Objectively Visualize the Etiology of Recurrent Atrial Fibrillation Following a Failed AF Ablation (RECOVER AF)
Enrollment Status: Completed
Publish Date: July 27, 2022
Intervention Type: Device
Study Phase: Not Applicable
AtaCor Subcostal Temporary Extravascular Pacing III Study
AtaCor Subcostal Temporary Extravascular Pacing III Study
Enrollment Status: Completed
Publish Date: July 07, 2022
Intervention Type: Device
Study Phase: Not Applicable
PEFCAT II: Expanded Safety and Feasibility Study of the FARAPULSE Endocardial Multi Ablation System to Treat Paroxysmal Atrial Fibrillation
PEFCAT II: Expanded Safety and Feasibility Study of the FARAPULSE Endocardial Multi Ablation System to Treat Paroxysmal Atrial Fibrillation
Enrollment Status: Completed
Publish Date: May 04, 2022
Intervention Type: Device
Study Phase: Not Applicable
AcQBlate Force Confirmatory Study for Atrial Arrhythmias (AcQBlate Force-PRA)
AcQBlate Force Confirmatory Study for Atrial Arrhythmias (AcQBlate Force-PRA)
Enrollment Status: Withdrawn
Publish Date: October 20, 2021
Intervention Type: Device
Study Phase: Not Applicable
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Enrollment Status: Completed
Publish Date: September 17, 2021
Intervention Type: Device, Other
Study Phase: Not Applicable
Subcostal Temporary Extracardiac Pacing II (STEP II) Study
Subcostal Temporary Extracardiac Pacing II (STEP II) Study
Enrollment Status: Completed
Publish Date: June 11, 2021
Intervention Type: Device
Study Phase: Not Applicable
A Prospective Single Arm Clinical Evaluation for the Characterization of the Safety Profile of the DiamondTemp™ System for Fast Treatment of Patients With Atrial Fibrillation
A Prospective Single Arm Clinical Evaluation for the Characterization of the Safety Profile of the DiamondTemp™ System for Fast Treatment of Patients With Atrial Fibrillation
Enrollment Status: Completed
Publish Date: February 03, 2021
Intervention Type: Device
Study Phase: Not Applicable
Adjunctive Renal Denervation to Modify Hypertension and Sympathetic Tone as Upstream Therapy in the Treatment of Atrial Fibrillation
Adjunctive Renal Denervation to Modify Hypertension and Sympathetic Tone as Upstream Therapy in the Treatment of Atrial Fibrillation
Enrollment Status: Completed
Publish Date: November 05, 2020
Intervention Type: Device
Study Phase: Not Applicable
REnal SympathetiC Denervation to sUpprEss Tachyarrhythmias in ICD Recipients
REnal SympathetiC Denervation to sUpprEss Tachyarrhythmias in ICD Recipients
Enrollment Status: Completed
Publish Date: March 04, 2020
Intervention Type: Device
Study Phase: Not Applicable
Dipole Density Right (and Left) Atrial Mapping and Assessment of Therapy In Complex Supraventricular Tachycardia
Dipole Density Right (and Left) Atrial Mapping and Assessment of Therapy In Complex Supraventricular Tachycardia
Enrollment Status: Completed
Publish Date: September 18, 2019
Intervention Type: Device
Study Phase: Not Applicable
Rook Epicardial Access Device Study
Rook Epicardial Access Device Study
Enrollment Status: Completed
Publish Date: March 29, 2019
Intervention Type: Device
Study Phase: Not Applicable
First-In-Human Study for Ultrasound Based Endovascular Carotid Body Ablation in Subjects With Treatment-Resistant Hypertension: A Safety and Feasibility Study
First-In-Human Study for Ultrasound Based Endovascular Carotid Body Ablation in Subjects With Treatment-Resistant Hypertension: A Safety and Feasibility Study
Enrollment Status: Unknown
Publish Date: April 10, 2018
Intervention Type: Device
Study Phase: Not Applicable
View 33 Less Clinical Trials

282 Total Publications

Cost-consequence analysis of three cardiac ablation technologies in paroxysmal atrial fibrillation.
Cost-consequence analysis of three cardiac ablation technologies in paroxysmal atrial fibrillation.
Journal: Journal of medical economics
Published: October 15, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Neuzil's expertise for a condition
ConditionClose
View All 8 Distinguished Conditions
View All 12 Advanced Conditions
View All 11 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile